Sangeun Jeon

Title: Sangeun Jeon: Innovator in Pharmaceutical Composition for COVID-19

Introduction

Sangeun Jeon is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the context of combating coronavirus disease 2019 (COVID-19). His innovative approach utilizes drug repositioning technology to find new applications for existing medications.

Latest Patents

Sangeun Jeon holds a patent for a pharmaceutical composition aimed at preventing or treating COVID-19. This invention focuses on a composition derived from drug repositioning technology, which employs virtual screening methods to identify new uses for already established drugs. The composition is particularly advantageous as it exhibits significantly lower side effects compared to newly developed drugs and can be swiftly integrated into clinical practice.

Career Highlights

Throughout his career, Sangeun Jeon has been associated with prestigious institutions such as the Korea Advanced Institute of Science and Technology and Institut Pasteur Korea. His work has been instrumental in advancing the understanding and treatment of viral diseases.

Collaborations

Sangeun Jeon has collaborated with esteemed colleagues, including Sang Yup Lee and Woo Dae Jang. These partnerships have further enriched his research and innovation efforts.

Conclusion

Sangeun Jeon's contributions to pharmaceutical science, particularly in the fight against COVID-19, highlight his role as a key innovator in the field. His work exemplifies the importance of drug repositioning technology in developing effective treatments.